BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32027882)

  • 1. Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient.
    Pham MN; Hudnall MT; Nadler RB
    Urology; 2020 May; 139():8-13. PubMed ID: 32027882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
    Basinski H; Jensen HB; Stenager E
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and cannabinoids in cancer pain management.
    Meng H; Dai T; Hanlon JG; Downar J; Alibhai SMH; Clarke H
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):87-93. PubMed ID: 32332209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and cannabinoids.
    Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review.
    Taylor C; Birch B
    Urology; 2021 Feb; 148():8-25. PubMed ID: 33129871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis for Symptom Management in Older Adults.
    Levy C; Galenbeck E; Magid K
    Med Clin North Am; 2020 May; 104(3):471-489. PubMed ID: 32312410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
    Cooper ZD; Abrams DI
    Am J Drug Alcohol Abuse; 2019; 45(6):580-595. PubMed ID: 31687845
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in the Treatment of Epilepsy.
    Friedman D; Devinsky O
    N Engl J Med; 2015 Sep; 373(11):1048-58. PubMed ID: 26352816
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
    Häuser W; Petzke F; Fitzcharles MA
    Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
    Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
    Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
    Hill KP
    JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis-based medicinal products: summary of NICE guidance.
    Chang-Douglass S; Mulvihill C; Pilling S;
    BMJ; 2020 Apr; 369():m1108. PubMed ID: 32317246
    [No Abstract]   [Full Text] [Related]  

  • 17. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review.
    Naik H; Trojian TH
    Curr Sports Med Rep; 2021 Jul; 20(7):345-350. PubMed ID: 34234089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and multiple sclerosis.
    Fragoso YD; Carra A; Macias MA
    Expert Rev Neurother; 2020 Aug; 20(8):849-854. PubMed ID: 32515670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.